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(57) 	 ABSTRACT 
Systems and methods for preparing a sample for further 
analysis are provided. The system can include an enclosure. A 
membrane can be disposed within the enclosure. First and 
second reservoirs can be disposed within the enclosure, and at 
least one of the first and second reservoirs can be adapted to 
have a reagent disposed therein. A valve can be disposed 
within the enclosure and in fluid communication with the first 
or second reservoirs or both. The valve can also be in fluid 
communication with the membrane. The valve can be adapted 
to selectively regulate the flow of the reagent from the first 
reservoir, through the membrane, and into the second reser-
voir. 
17 Claims, 10 Drawing Sheets 
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PREPARATION SYSTEM AND METHOD 
CROSS-REFERENCE TO RELATED 
APPLICATIONS 
This application claims the benefit of a related U.S. Provi-
sional Application Ser. No. 61/680,075 filed Aug. 6, 2012, 
entitled "Pre-Polymerase Chain Reaction Preparation Kit," 
the disclosure of which is incorporated by reference herein in 
its entirety. 
ORIGIN OF THE INVENTION 
The invention described herein was made in the perfor-
mance of work under a NASA contract and is subject to the 
provisions of Section 305 of the National Aeronautics and 
Space Act of 1958, Public Law 85-568 (6052 Star. 435; 42 
U.S.C. 233605). 
BACKGROUND 
Field 
Embodiments described herein generally relate to appara-
tus, systems, and methods for the isolation and/or preparation 
of biological and non-biological samples for further analysis, 
such as pre-analysis sample-reagent mixing, distributing, and 
loading. 
SUMMARY 
2 
through the valve. At least a portion of the first mixture can 
flow through the second flow path and into the third reservoir 
containing a second reagent to form a second mixture. The 
method can be performed to enable elution, dilution, mixing, 
5 distribution, or loading of a sample. 
BRIEF DESCRIPTION OF THE DRAWINGS 
FIG. 1 depicts a cross-sectional perspective view of an 
10 illustrative sample preparation system, according to one or 
more embodiments described. 
FIGS. 2A-2C depict cross-sectional views of the prepara-
tion assembly depicted in FIG. 1 during a process for prepa-
ration of a sample, according to one or more embodiments 
15 described. 
FIG. 3 depicts a cross-sectional view of the fourth injector 
of the preparation assembly in fluid communication with a 
distributor, according to one or more embodiments described. 
FIG. 4 depicts a cross-sectional view of the distributor in 
20 fluid communication with one or more containers, according 
to one or more embodiments described. 
FIGS. 5A-5C depict partial cross-sectional perspective 
views of another illustrative embodiment of a sample prepa-
ration assembly having a second valve in fluid communica- 
25 tion withthe containers via the distributor, according to one or 
more embodiments described. 
FIG. 6 depicts a perspective view of a plurality of prepa-
ration assemblies in fluid communication with the containers 
via the distributor, according to one or more embodiments 
30 described. 
This summary is provided to introduce a selection of con-
cepts that are further described below in the detailed descrip-
tion. This summary is not intended to identify key or essential 
features of the claimed subject matter, nor is it intended to be 35 
used as an aid in limiting the scope of the claimed subject 
matter. 
Systems and methods for releasing biological and non-
biological samples of interest, such as nucleic acids or other 
samples, from a membrane are disclosed. The system, which 40 
may be self-enclosed and automated for use in space or ter-
restrial environments, can include an enclosure. A membrane 
can be disposed within the enclosure. First and second reser-
voirs can be disposed within the enclosure, and at least one of 
the first and second reservoirs can have a reagent disposed 45 
therein. A valve, such as a multi-way valve, can be disposed 
within the enclosure and in fluid communication with the first 
or second reservoirs, or both. The valve can also be in fluid 
communication with the membrane. The valve can be adapted 
to selectively regulate the flow of the reagent from the first 50 
reservoir, through the membrane, and into the second reser-
voir. The system can be used for sample-reagent mixing, 
distributing, and loading. In one embodiment, when the sys-
tem is used, an analyte or other sample can be isolated or 
prepared for further analysis, such as real-time polymerase 55 
chain reaction, without exposure to its external environment. 
The method can include flowing a first reagent with liquid 
samples through a first flow path between a first reservoir and 
a second reservoir. The first flow path can extend through a 
valve, or a valve and a membrane. An analyte of interest, such 60 
as nucleic acids or other samples, can be released from the 
membrane when contacted with the first reagent to form a first 
mixture including the first reagent and the released nucleic 
acids or other samples. Or, liquid samples can be directly 
introduced to the second reservoir from the first reservoir 65 
through the valve. The valve can be rotated to form a second 
flow path between the second reservoir and a third reservoir 
DETAILED DESCRIPTION 
FIG. 1 depicts a cross-sectional perspective view of an 
illustrative sample preparation system 100, according to one 
or more embodiments described herein. The sample prepara-
tion system 100 can include one or more elution/sample 
preparation assemblies 200 and one or more distribution 
assemblies 300. The sample preparation system 100 is a 
pipette-free, closed system adapted to limit or prevent expo-
sure to an external environment. In one embodiment, the 
sample preparation system 100 can be used in a microgravity 
environment. As a closed system, fluid disposed within the 
system 100 does not escape or leak out, as would occur with 
traditional open-ended pipettes, particularly when used in 
microgravity environments in space. 
FIGS. 2A-2C depict cross-sectional views of the prepara-
tion assembly 200 depicted in FIG. 1 during a process for 
preparation of a sample, according to one or more embodi-
ments. The preparation assembly 200 can include one ormore 
injectors (four are shown 210, 220, 230, 240), one or more 
valves (one is shown 250), and one or more membranes (one 
is shown 260). Although not shown, in at least one embodi-
ment, the preparation assembly 200 can include two injectors 
210, 220 having the membrane 260 disposed therebetween. 
In this embodiment, the additional injectors 230, 240 and the 
valve 250 can be omitted. 
The injectors 210, 220, 230, 240 can include one or more 
components. For example, each injector 210, 220, 230, 240 
can have a chamber or reservoir 214, 224, 234, 244 disposed 
therein, respectively. Each injector 210, 220, 230, 240 can 
also have a piston 212, 222, 232, 242, respectively, adapted to 
slide axially therein. Axial movement of the piston 212, 222, 
232, 242 within its respective injector 210, 220, 230, 240 can 
push fluid out of its respective reservoir 214, 224, 234, 244 
and into one of the reservoirs 214, 224, 234, 244 of another 
injector. Similarly, axial movement of the piston 212, 222, 
US 9,017,621 B1 
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232, 242 within its respective injector 210, 220, 230, 240 can 
also draw fluid into its respective reservoir 214, 224, 234, 244 
from one of the reservoirs 214, 224, 234, 244 of another 
injector. 
At least one of the pistons 212, 222, 232, 242 can have a 
bore formed axially therethrough such that the bore forms a 
path of fluid communication between the reservoir and the 
exterior of the injector 210, 220, 230, 240. As shown in FIG. 
2A, the fourthpiston 242 has a bore 246 formed therethrough. 
The bore 246 can allow fluid to be injected into or withdrawn 
from the reservoir 244 of the fourth injector 240, as described 
in more detail below. 
At least one of the injectors 210, 220, 230, 240 can have an 
interface 226 adapted to receive a light source 228, such as a 
spectrophotometer, illuminometer, and/or fluorometer. The 
light source 228 can be adapted to measure the reflection, 
emission, or transmission properties of the fluid within the 
reservoir 224 as a function of its wavelength. The interface 
226 can be any shape, including round, flat, or the like that fits 
the adapted light source 228. In at least one embodiment, the 
light source 228 can be a nanodrop (ND) 2000c spectropho-
tometer. 
The valve 250 can be disposed within the preparation 
assembly 200 and coupled to at least one of the injectors 210, 
220, 230, 240 such that the reservoirs 214, 224, 234, 244 of 
the injectors 210, 220, 230, 240 can be in fluid communica-
tion with one another through the valve 250. In at least one 
embodiment, one or more of the injectors 210, 220, 230, 240 
can be operatively connected, such as by threadable engage-
ment or other method of attachment, with the valve 250. 
Although not shown, tubing having a diameter similar to the 
diameter of the flow path through the valve 250, e.g., 
15-gauge, can be coupled to and disposed between the injec-
tors 210, 220, 230, 240 and the valve 250 to provide more 
flexibility in the layout or configuration of the preparation 
assembly 200. 
The valve 250 can include a rotatable housing having at 
least one bore formed therethrough. In FIGS. 1 and 2A-2C, 
the valve 250 has two bores shown, but one bore will be 
discussed in further detail with reference to the FIGS. 2A-2C 
during operation of the preparation system. The valve 250 can 
be actuated or rotated to provide more than one path of fluid 
communication among the plurality of reservoirs 214, 224, 
234, 244, i.e., the valve may be considered to be a "multi-
way" valve. In one embodiment, a suitable valve 250 can be 
or include those manufactured by the Hamilton Company in 
Reno, Nev. 
In at least one embodiment, the membrane 260 can have 
isolated nucleic acids, such as DNA and/or RNA disposed 
thereon. The term "membrane," as used herein, refers to any 
material or layer(s) of material that acts as a selective barrier, 
allowing fluids and some particles to pass therethrough, while 
other particles are not allowed to pass therethrough, and are 
instead retained therein. 
The membrane 260 can be disposed within a membrane 
support assembly 262, and the membrane support assembly 
262 can be disposed within the preparation assembly 200. In 
at least one embodiment, the membrane support assembly 
262 can be disposed between one of the injectors 210, 220, 
230, 240 and the valve 250. For example, the membrane 
support assembly 262 can be operatively connected, such as 
by being threadably engaged or otherwise attached, with the 
first injector 210 and the valve 250. The support assembly 262 
can be perforated and disposed adjacent to opposing surfaces 
of the membrane 260. As such, fluid can pass or flow through 
the membrane 260 and the membrane support assembly 262. 
4 
A suitable membrane 260 can include one or more 
micropores. In one embodiment, the micropores can have an 
average pore diameter ranging from a low of about 0.2 µm, 
about 0.4 µm, or about 0.6 µm to a high of about 1 µm, about 
5 2µm, about 3 µm, about 4 µm, about 5 µm, or more for 
RNA/DNA isolation and/or preparation. However, for other 
applications, the micropores can have an average pore diam-
eter ranging from a low of about 0.0001 µm, about 0.001 µm, 
or about 0.01 µm to a high of about 0.05 µm, about 0.1 µm, or 
io about 0.2 µm (e.g., for protein isolation or separation), or 
from a low of about 10 µm, about 20 µm, or about 30 µm to a 
high of about 50 µm, about 75 µm, or about 100 µm (e.g., for 
filtering single cell suspensions). The membranes can also be 
used for binding, isolating, and separating specific molecules 
15 and particles, isolating specific types of cells, and reagent 
sterilization. 
The membrane 260 can be, but is not limited to, a protein-
ase membrane, a homogenizing membrane, a filtering mem-
brane, a binding membrane, or any combination thereof. For 
20 example, the membrane 260 can be a binding membrane 
having precipitated nucleic acids bound thereto. Suitable 
membranes 260 can also include a solid surface functional-
ized with immobilized active enzymes and high density 
enzyme surfaces. More specifically, suitable membranes 260 
25 can include a solid surface functionalized with immobilized 
proteinase, such as trypsin, chymotrypsin, endoproteinase 
G1uC, papain, endoproteinase pepsin, proteinase K, and the 
like. Suitable solid surfaces can also include glass fiber, glass 
fiber treated with oleophobic coatings, silica particles or 
3o beads, silica particles or beads coated with oleophobic coat-
ings, nylon, and other oleophobic materials, and the like. For 
example, suitable membranes can include the DigesTip pro-
duced by ProteoGen Bio in Siena, Italy. Suitable membranes 
260 can also include, but are not limited to, membranes found 
35 in a standard kit for the purification of DNA or RNA, such as 
the commercially available kit sold by the manufacturer 
Qiagen, (e.g., DNeasy Blood and Tissue Kit, RNeasy Mini 
Kit, RNeasy Protect Mini Kit, and RNeasy Plant Mini Kit). In 
at least one embodiment, the surface can be coated with 
40 complementary oligo nucleotides, antibodies, covalently or 
non-covalently binding to target molecules, and/or any par-
ticles and membranes used for separating molecules based on 
size and isoelectric point. 
One or more control systems 270 can be in communication 
45 with the preparation assembly 200. In at least one embodi-
ment, the control system 270 can be adapted to measure the 
volume of fluid within the reservoirs 214, 224, 234, 244, 
measure the concentration of nucleic acids disposed in the 
fluid within the reservoirs 214, 224, 234, 244, and/or actuate 
50 the pistons 212, 222, 232, 242 to cause a calculated amount of 
fluid to flow between reservoirs 214, 224, 234, 244. The 
control system 270 can serve as a digital volume control and 
automatic distributor of fluid within the preparation assembly 
200. 
55 	 FIG. 3 depicts a cross-sectional view of the fourth injector 
240 of the preparation assembly 200 in fluid communication 
with a distributor or manifold 310 of distribution assembly 
300, and FIG. 4 depicts a cross-sectional view of the distribu-
tor 310 in fluid communication with one or more containers or 
60 tubes 320, according to one or more embodiments. The dis-
tribution assembly 300 can include the distributor 310 and 
one or more tubes or containers (eight are shown 320). The 
distributor 310 can include an inlet 312 in fluid communica-
tion with one or more outlets 314. The outlets 314 can be 
65 made of any material (plastic, metal, etc.) and sized to fit 
within the containers 320. In at least one embodiment, the 
inlet 312 can be coupled to the fourth injector 240 directly, or 
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6 
through a flexible conduit or tube to allow more adaptability 	 reservoir 224 can range from a low of about 0.1 mL, about 0.2 
in configuration and to allow multi-sample preparation. Fur- 	 mL, about 0.4 mL, about 0.6 mL, about 0.8 mL, or about 1.0 
ther, the inlet 312 may be configured to be in fluid commu- 	 mL to a high of about 2.0 mL, about 3.0 mL, about 4.0 mL, 
nication with the fourth reservoir 244 through the bore 246 in 	 about 5.0 mL, or more. In at least one embodiment, the first 
the piston 242. Each outlet 314 can be adapted to be inserted 5 reagent can include water. In another embodiment, the first 
into a container 320, as shown in FIG. 4. The number of 	 reagent can be a TE buffer (such as 10 mM Tris-Cl/1 mM 
outlets 314 and/or containers 320 can range from a low of 1, 	 EDTA, having a pH of about 7.5), an EB buffer (such as 10 
2, 4, 6, 8, or 10 to a high of about 15, 20, 25, 30, 35, 40, or 	 mM Tris-Cl, having a pH of about 8.5), or the like. The second 
more. The distributor 310 can be designed with additional 	 piston 222 can be pressed, thereby forcing the first reagent 
inlets to communicate with the exterior to allow washing and i o through the first flow path 280 and into the first reservoir 214. 
creation of a vacuum within each container 320. 	 As the first reagent contacts the first membrane 260, the first 
The containers 320 can be made of glass or plastic and 	 reagent can cause the sample of interest, such as nucleic acids 
define an internal volume. The internal volume can range 	 (e.g., DNA and/or RNA), bound to the first membrane 260 to 
from a low of about 0.25 mL, about 0.5 mL, about 1 mL, about 	 release therefrom and become disposed or suspended in the 
2 mL, about 3 mL, about 4 mL, or about 5 mL to a high of 15 first reagent, forming a first mixture in the first reservoir 214. 
about 6 mL, about 8 mL, about 10 mL, about 15 mL, about 20 
	
The first piston 212 can thenbepressed, thereby forcing the 
mL, or more. Each container 320 can include a seal 322 (e.g., 	 first mixture back through the first flow path 280 and into the 
a rubber seal) proximate a first end 324 thereof. The seal 322 	 second reservoir 224. The concentration of the samples, such 
can be adapted to prevent fluid from leaking into or out of the 	 as the nucleic acids, within the first mixture can be measured. 
container 320. Each container 320 can also have a piston or 20 For example, the control system 270, operatively connected 
plug 328 disposed therein and coupled to the seal 322. The 	 and using the light source 228, can measure the concentration 
plug 328 can be adapted to sealingly engage the inner walls of 	 of the samples of interest, such as nucleic acids, within the 
the container 320 and slide axially therein. The plug 328 can 	 first mixture. 
have a bore formed axially therethrough, and a tube 330 can 	 Referring now to FIG. 213, the valve 250 can then be rotated 
be disposed within the bore. The tube 330 can have a diameter 25 to provide a second flow path 282 between the second and 
ranging from a low of about zero (0) (e.g., when the outlet 314 	 third reservoirs 224, 234. The third reservoir 234 can include 
is not inserted), about 0.5 mm, about 1 mm, or about 2 mm to 	 a second reagent. The volume of the second reagent in the 
a high of about 4 mm, about 6 mm, about 8 mm, or more. Each 	 third reservoir 234 can range from a low of about 0.1 mL, 
tube 330 can be adapted to have one of the outlets 314 of the 	 about 0.2 mL, about 0.4 mL, about 0.6 mL, about 0.8 mL, or 
distributor 310 inserted into it. 	 3o about 1.0 mL to a high of about 2.0 mL, about 3.0 mL, about 
Accordingly, each outlet 314 can extend through the seal 
	
4.0 mL, about 5.0 mL, or more. In at least one embodiment, 
322, the plug 328, and/or the tube 330 to introduce fluids into 	 the second reagent can include water or any other suitable 
the corresponding container 320. Once the outlet 314 is 	 dilutionbuffer. The secondpiston 222 can bepressed, thereby 
inserted into and in fluid communication with the container 	 forcing at least a portion the first mixture through the second 
320, the plug 328 can be moved toward the first end 324 of the 35 flow path 282 and into the third reservoir 234, forming a 
container 320 generating a vacuumed space between the plug 	 second mixture including the first mixture and the second 
328 and a second end 326 of the container 320. At the same 	 reagent in the third reservoir 234. 
time, the piston 242 (in this example the representative injec- 	 The amount of the first mixture introduced to the third 
tor connected is injector 240) will move up to release the 	 reservoir 234 can depend, at least in part, on the concentration 
mixture from the fourth reservoir 244. For example, an actua-  40 of the samples of interest, such as the concentration of nucleic 
tor 332 can be coupled to the container 320 and adapted to 	 acids disposed within the first mixture. For example, as the 
move or pull the corresponding plug 328 toward the first end 	 amount of the first mixture introduced to the third reservoir 
324 of the container 320 to create the vacuumed space. In at 	 234 increases, the concentration of the second mixture 
least one embodiment, each container 320 can include its own 	 increases; however, as the amount of the first mixture intro- 
actuator 332, and the actuators 332 can be coupled together to 45 duced to the third reservoir 234 decreases, the second mixture 
move a plurality of plugs 328 simultaneously. In another 	 becomes more diluted. In at least one embodiment, a ratio of 
embodiment, a single actuator 332 canbe adapted to move the 	 DNA to the total volume of the first and/or second mixture can 
plurality of plugs 328 in a plurality of containers 320 simul- 	 range from a low of about 0.4 ng/ltL, about 0.8 ng/ltL, about 
taneously. The vacuumed space can induce the fluid from the 	 1.2 ng/ltL, about 1.6 ng/ltL, or about 2.0 ng/ltL to a high of 
fourth reservoir 244 to flow through the bore 246 in the piston 5o about 3.0 ng/ltL, about 4.0 ng/ltL, or about 5.0 ng/ltL. In 
242 and the distributor 310 and into one or more of the 	 another embodiment, a ratio of RNA to the total volume of the 
containers 320, as described in more detail below. Once the 	 first and/or second mixture can range from a low of about 0.05 
fluid is introduced, the seal 322 can prevent the fluids from 	 ng/ltL, about 0.10 ng/ltL, about 0.20 ng/ltL, about 0.30 ng/ltL, 
leaking into or out of the container 320. 	 or about 0.40 ng/ltL to a high of about 1.0 ng/ltL, 1.2 ng/ltL, 
Now referring to FIGS. 1-4, in operation, the membrane 55 about 1.4 ng/ltL, about 1.6 ng/ltL, about 1.8 ng/ltL, or about 
260 having the sample of interest, such as nucleic acids, 	 2.0 ng/ltL. 
bound thereto can be disposed within the membrane support 	 The valve 250 can then be rotated to provide a third flow 
assembly 262, and the membrane support assembly 262 can 	 path 284 between the third and fourth reservoirs 234, 244 (see 
be operatively positioned within the preparation assembly 	 FIG. 2C). The fourth reservoir 244 can include a third reagent. 
200. For example, the membrane support assembly 262 can 6o The volume of the third reagent in the fourth reservoir 244 can 
be threadably engaged withthe first injector 210 and the valve 	 range from a low of about 0.1 mL, about 0.2 mL, about 0.4 
250. 	 mL, about 0.6 mL, about 0.8 mL, or about 1.0 mL to a high of 
The valve 250 can be rotated to provide a first flow path 280 	 about 2.0 mL, about 3.0 mL, about 4.0 mL, about 5.0 mL, or 
between the first and second reservoirs 214, 224 (see FIG. 	 more. In at least one embodiment, the third reagent can 
2A). The first flow path 280 can extend through the valve 250 65 include a Polymerase Chain Reaction (PCR) master mix. The 
and the membrane 260. The second reservoir 224 can include 	 PCR master mix can include DNA polymerase, a buffer, and 
a first reagent. The volume of the first reagent in the second 
	
deoxynucleoside triphosphates (dNTPs). Suitable PCR mas- 
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ter mixes can include the Taq PCR Master Mix commercially 
available from Qiagen, Inc. in Valencia, Calif. In at least one 
embodiment, when the second mixture includes RNA as the 
sample of interest, the second mixture can be mixed with 
reverse transcriptase prior to being combined with the PCR 5 
master mix in the fourth reservoir 244. In another embodi-
ment, the reverse transcription polymerase chain reaction can 
be completed in a single step. When the preparation assembly 
200 is coupled with another assembly (not shown), such as the 
isolation assembly shown and described in U.S. patent appli- io 
cation Ser. No. 13/461,487 entitled "System and Method for 
Isolation of Samples," the entire content of which is hereby 
incorporated herein by reference, the RNA and reverse tran-
scriptase can be injected first to complete reverse transcrip-
tion, andthen PCRmix can be injected from another reservoir 15 
to complete PCR. 
Following the rotation of valve 250 to provide third flow 
path 284, the third piston 232 can be pressed, thereby forcing 
at least a portion of the second mixture through the third flow 
path 284 and into the fourth reservoir 244, forming a third 20 
mixture including the second mixture and the third reagent. In 
at least one embodiment, the valve 250 can then be rotated to 
form the flow path 280 (as shown in FIG. 2A) or the flow path 
282 (as shown in FIG. 213), particularly when only one bore is 
present within valve 250, such that the valve 250 is "closed" 25 
to the fourth reservoir 244. In another embodiment, a second 
bore may be present within valve 250 that is constructed with 
a check valve to permit flow of fluid in only one direction, 
such as in this embodiment from the third reservoir 234 to the 
fourth reservoir 244, thereby preventing back flow of the third 30 
mixture and effectively "closing" the fourth reservoir 244 in 
an alternate manner. In at least one embodiment, the actuators 
332 can then move the plugs 328 toward the first end 324 of 
the containers 320 inducing the vacuumed space between the 
plugs 328 and the second end 326 of the containers 320 (see 35 
FIGS. 3 and 4). The vacuumed space can induce the third 
mixture to flow from the fourthreservoir 244 through the bore 
246 in the piston 242 and toward the distributor 310. In 
another embodiment, the piston 242 of the fourth injector 240 
can be pressed forcing the third mixture through the bore 246 40 
in the piston 242 and toward the distributor 310. 
The third mixture can flow into the distributor 310 via the 
inlet 312 and split or be divided among one or more outlets 
314. The third mixture can then flow out the distributor 310 
via the outlets 314 and into the containers 320, as shown in 45 
FIG. 4. The third mixture can be introduced to the vacuumed 
space in the containers 320 between the second end 326 and 
the plug 328. In at least one embodiment, the containers 320 
can include a fourth reagent (which may be dried or liquid) 
disposed therein. Thus, the third mixture can be combined 50 
with the fourth reagent in the containers 320 to form a fourth 
mixture therein. The volume of the fourth reagent in each 
container 320 canrange from a low of about zero (0, i.e., dried 
form), 0.01 mL, about 0.02 mL, about 0.05 mL, about 0.10, 
about 0.2 mL, about 0.5 mL, or about 1.0 mL to a high of 55 
about 2.0 mL, about 3.0 mL, about 4.0 mL, about 5.0 mL, or 
more. In at least one embodiment, the fourth reagent can be 
suspended, or bind to the bottom of the container, including 
oligonucleotide primers, probes, enzymes, buffers, inhibi-
tors, activators in either dried form or liquid form, fluoro- 60 
phore labeled or colorimetric analysis, or the like. 
Once the third mixture has been introduced to the contain-
ers 320, the outlets 314 of the distributor 310 can then be 
withdrawn from the containers 320. The seals 322 and the 
plugs 328 can secure the fourth mixture within the containers 65 
320. A cap (not shown) can also be placed on the first end 322 
of the container 320 to add an additional sealing element. For 
example, the cap can be threaded onto the first end 322 of the 
container 320. The container 320 can then be used for poly-
merase chain reactions or other processes. 
FIGS. 5A-5C depict perspective cross-sectional views of 
another illustrative embodiment of the preparation assembly 
200 in fluid communication with the containers 320 via the 
distributor assembly 300, according to one or more embodi-
ments. As shown, the preparation assembly 200 can include a 
second valve 550 in fluid communication with the first valve 
250. In another embodiment, the preparation assembly 200 
can include a second valve 550 in fluid communication with 
the fourth injector 240 (not shown). One or more injectors 
(two are shown 510, 520) can be coupled to the second valve 
550. 
In at least one embodiment, the first and second valves 250, 
550 can be rotated to form a flow path into a fifth reservoir 514 
in the fifth injector 510. Referring to FIG. 5A, the third piston 
232 can be pressed, thereby forcing at least a portion of the 
second mixture through the flow path 584 into the fifth res-
ervoir 514, forming a third mixture including the second 
mixture and a fourth reagent. The fourth reagent can include 
any one or more of the reagents discussed above. 
The second valve 550 can then be rotated to provide a flow 
path 586 as shown in FIG. 5B between the fifth reservoir 514 
and the containers 320 (via the distributor assembly 300). The 
fifth piston 512 can be pressed, thereby forcing at least a 
portion of the third mixture through the distributor assembly 
300 and into at least one of the containers 320. As shown in 
FIG. 5C, the second valve 550 can then be rotated to form a 
flow path 588 between the sixth reservoir 524 and the con-
tainers 320 via the distributor assembly 300. The sixth piston 
522 can then be pressed, thereby forcing at least a portion of 
a fifth reagent into the containers 320 to mix with the third 
mixture. The fifth reagent can include any one or more of the 
reagents discussed above. 
In at least one embodiment, prior to transferring the mix-
ture (e.g., from the fifth reservoir 514 and/or the sixth reser-
voir 524, or from the fourth reservoir 244) from the prepara-
tion assembly 200 to the containers 320 via the distributor 
assembly 300, the distributor 310 can be soaked or rinsed in 
one or more buffers (such as by placement in a container of 
buffer solution or by introducing buffer(s) through the inlet 
312). Suitable buffers can include, but are not limited to, 
deionized water, ribonuclease (RNase) free water, or the like. 
After soaking in the buffer solution, the mixture can be drawn 
into the distributor 310 until the mixture approaches the tip of 
the outlets 314. At this time, the outlets 314 can be inserted 
into the containers 320. By drawing the mixture into the 
distributor 310 and proximate the tip of the outlets 314, 
bubbles may be reduced or prevented in the containers 320. 
FIG. 6 depicts a perspective view of a plurality of prepa-
ration assemblies 200, 600, 700, 800 in fluid communication 
with the containers 320 via the distributor assembly 300, 
according to one or more embodiments described. A plurality 
of preparation assemblies (four are shown 200, 600, 700, 800) 
can be in fluid communication with the containers 320 via the 
distributor 310. As shown, tubes 248, 648, 748, 848 may be 
coupled respectively to the corresponding fourth injector 240, 
640, 740, 840 of each preparation assembly. Tubes 248, 648, 
748, 848 may provide a path of fluid communication from 
each respective fourth reservoir 244, 644, 744, 844 to the 
distributor assembly 300. Eachtube248, 648, 748, 848 can be 
coupled to the same distributor assembly 300, or each tube 
248, 648, 748, 848 can be coupled to a different distributor 
assembly (not shown). 
Certain embodiments and features have been described 
using a set of numerical upper limits and a set of numerical 
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lower limits. It should be appreciated that ranges from any 
lower limit to any upper limit are contemplated unless other-
wise indicated. Certain lower limits, upper limits, and ranges 
appear in one or more claims below. All numerical values are 
"about" or "approximately" the indicated value, and take into 
account experimental error and variations that would be 
expected by a person having ordinary skill in the art. The 
reagents listed are mainly for real-time PCR or RT-PCR. For 
other applications, such as enzymatic assay, luminal assay, 
ELISA, the reagents may vary. 
Various terms have been defined above. To the extent a 
term used in a claim is not defined above, it should be given 
the broadest definition persons in the pertinent art have given 
that term as reflected in at least one printed publication or 
issued patent. Furthermore, all patents, test procedures, and 
other documents cited in this application are fully incorpo-
rated by reference to the extent such disclosure is not incon-
sistent with this application and for all jurisdictions in which 
such incorporation is permitted. 
Although only a few exemplary embodiments have been 
described in detail above, those skilled in the art will readily 
appreciate that many modifications are possible in the exem-
plary embodiments without materially departing from the 
novel teachings and advantages of this invention. Accord-
ingly, all such modifications are intended to be included 
within the scope of this invention as defined in the following 
claims. In the claims, means-plus-function and step-plus-
function clauses are intended to cover the structures or acts 
described herein as performing the recited function and not 
only structural equivalents, but also equivalent structures. 
Thus, although a nail and a screw may not be structural 
equivalents in that a nail employs a cylindrical surface to 
secure parts together, whereas a screw employs a helical 
surface, in the environment of fastening parts, a nail and a 
screw may be equivalent structures. 
What is claimed is: 
1. A preparation system, comprising: 
• first injector having a first reservoir disposed therein; 
• second injector having a second reservoir disposed 
therein; 
• valve disposed between the first and second reservoirs 
such that a path of fluid communication exists between 
the first and second reservoirs through the valve; 
• membrane disposed between the first reservoir and the 
valve such that the path of fluid communication extends 
through the membrane; 
• distributor having an inlet coupled to the second injector 
and in fluid communication with the second reservoir; 
and 
one or more containers coupled to an outlet of the distribu-
tor, wherein a reagent when disposed in the second res-
ervoir is capable of flowing from the second reservoir, 
through the distributor, and into the one or more con-
tainers. 
2. The preparation system of claim 1, wherein the second 
injector comprises a piston having a bore formed there-
through, and wherein the second reservoir is in fluid commu-
nication with the inlet of the distributor through the bore. 
3. The preparation system of claim 1, wherein the mem-
brane comprises nucleic acids bound thereto, and wherein 
when a reagent disposed in the second reservoir contacts the 
membrane, at least a portion of the nucleic acids are adapted 
to release from the membrane and become disposed within 
the reagent. 
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4. The preparation system of claim 1, further comprising a 
reagent disposed in the second reservoir. 
5. The preparation system of claim 4, further comprising a 
third injector coupled to the valve and having a third reservoir 
5 disposed therein, wherein the third reservoir comprises a 
polymerase chain reaction master mix disposed therein. 
6. The preparation system of claim 1, wherein each of the 
one or more containers comprises a plug disposed therein, 
wherein the plug is adapted to sealingly engage an inner wall 
of the container. 
10 	 7 The preparation system of claim 1, wherein the one or 
more containers are pre-vacuumed by moving a plug dis-
posed therein. 
8. A method for preparation of a biological sample for 
analysis using the preparation system of claim 1, wherein the 
15 method comprises contacting the biological sample with a 
reagent adapted to flow from the second reservoir, through the 
valve and the membrane, and into the first reservoir. 
9. The method of claim 5, wherein the reagent comprises 
between about 0.1 mL and about 3.0 mL of water. 
20 10. The method of claim 8, wherein the reagent comprises 
between about 0.1 mL and about 3.0 mL of a polymerase 
chain reaction master mix. 
11. The preparation system of claim 1, wherein the second 
injector comprises a piston disposed at least partially therein, 
25 and wherein a bore extends through the piston such that the 
bore is in fluid communication with the second reservoir. 
12. The preparation system of claim 1, further comprising 
a spectrophotometer in communication with an interface on 
the first injector, the second injector, or both. 
30 	 13. The preparation system of claim 1, wherein at least one 
of the first and second injectors is threadably engaged with the 
valve. 
14. A method of releasing nucleic acids from a membrane, 
comprising: 
35 	 providing a self-contained preparation system comprising 
a first reservoir, a second reservoir, a membrane for 
collecting nucleic acids disposed between the first res-
ervoir and the second reservoir, and a valve disposed 
between the first reservoir and the second reservoir and 
40 the membrane such that a path of fluid communication 
exists between the first and second reservoirs through 
the valve; 
flowing a first reagent through a first flow path between the 
first reservoir and the second reservoir, wherein the first 
45 flow path extends through the valve and the membrane, 
and wherein nucleic acids are released from the mem-
brane when contacted with a first reagent to form a first 
mixture comprising the first reagent and the released 
nucleic acids; 
50 positioning the valve to form a second flow path between 
the second reservoir and a third reservoir through the 
valve; and 
flowing at least a portion of the first mixture through the 
second flow path and into the third reservoir containing 
55 a second reagent to form a second mixture. 
15. The method of claim 14, wherein at least one of the first 
and second reagents comprises water. 
16. The method of claim 14, further comprising measuring 
a concentration of the nucleic acids disposed within the first 
60 mixture. 
17. The method of claim 14, further comprising flowing the 
second mixture through a distributor and into one or more 
containers for further analysis. 
